Otolaryngology Doctors in Longmont, CO Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Dr. Leslie Kayo Winter, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1925 Mountain View Ave, Longmont, CO 80501 Phone: 303-776-1234    Fax: 720-494-3107

Dr. Kevin Clifford Cavanaugh, MD Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 Dry Creek Dr, Suite 103, Longmont, CO 80503 Phone: 720-494-9111    Fax: 720-494-9555

Dr. Alfred Nathan Carr, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1750 Mountain View Ave, Longmont, CO 80501 Phone: 303-772-3204

Dr. Abby C Emdur, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1925 W Mountain View Ave, Longmont, CO 80501 Phone: 303-684-7880    Fax: 720-494-3107

Peter Michael Schmid, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1305 Sumner Street, Suite 100, Longmont, CO 80501 Phone: 303-651-6846    Fax: 303-651-6794

Dr. Jessica Lynn Birch, MD Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1925 Mountain View Ave, Longmont, CO 80501 Phone: 720-494-3120    Fax: 720-494-3113

News Archive

Are we over-dosing on antibiotics?

Dutch researchers say that a three day course of antibiotics is just as effective as the usual seven to 10 days course when it comes to treating common pneumonia.

Sleep apnea may increase risk of heart disease and death by 68%: Study

Obstructive sleep apnea (OSA) that leads to snoring and is actually caused by frequent collapse of the airway during sleep makes it difficult for sufferers to breathe for periods lasting as long as 10 seconds. Severe sufferers may have 30 such apnoeic or breathless episodes per hour that can severely disrupt sleep.

Brookhaven Science Associates, BioSET receive U.S. patent for tissue regeneration technology

Brookhaven Science Associates, the company that manages the U.S. Department of Energy's Brookhaven National Laboratory, and Biosurface Engineering Technologies, Inc. of Rockville, Maryland, have been issued a U.S. patent for an improved second-generation technology for designing synthetic peptides that are important for tissue regeneration.

FDA completes review of compounded hydroxyprogesterone caproate products and APIs

FDA (or the Agency) approved Makena (hydroxyprogesterone caproate) in February 2011 for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. Beginning many years before Makena was approved, a version of the active ingredient of Makena has been available to patients whose physicians requested the drug from a pharmacist who compounded the drug.

Special team care reduces cumulated stroke risk after transient ischaemic attacks

Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology.

Read more Medical News

› Verified 5 days ago